Arrowhead Pharmaceuticals (ARWR) News Today $22.03 -0.31 (-1.39%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$22.58 +0.56 (+2.52%) As of 08/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ARWR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Nuveen LLC Takes $4.31 Million Position in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 29 at 3:36 AM | marketbeat.comHighTower Advisors LLC Has $1.43 Million Stock Position in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 28 at 3:37 AM | marketbeat.comArrowhead Pharmaceuticals to Participate in Upcoming September 2025 ConferencesAugust 27 at 7:51 AM | mms.businesswire.comArrowhead Pharmaceuticals to Participate in Upcoming September 2025 ConferencesAugust 27 at 7:30 AM | businesswire.comCapital Fund Management S.A. Makes New $2.08 Million Investment in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 27 at 4:49 AM | marketbeat.comBrokerages Set Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) PT at $43.14August 27 at 2:15 AM | americanbankingnews.comPale Fire Capital SE Takes Position in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 26, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Raises Stock Position in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 26, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Boosts Holdings in Arrowhead Pharmaceuticals, Inc. $ARWRAugust 26, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Consensus Recommendation of "Buy" by AnalystsAugust 26, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. $ARWR Stock Position Raised by Vanguard Group Inc.August 23, 2025 | marketbeat.comAberdeen Group plc Buys 622,752 Shares of Arrowhead Pharmaceuticals, Inc. $ARWRAugust 21, 2025 | marketbeat.comPublic Sector Pension Investment Board Invests $5.09 Million in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)August 19, 2025 | marketbeat.comFY2025 Earnings Estimate for ARWR Issued By Leerink PartnrsAugust 19, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Insider James C. Hamilton Sells 611 SharesAugust 17, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Insider Sells $187,780.00 in StockAugust 17, 2025 | marketbeat.comHC Wainwright Has Bearish Outlook for ARWR FY2025 EarningsAugust 17, 2025 | marketbeat.comE Fund Management Co. Ltd. Purchases Shares of 18,017 Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)August 17, 2025 | marketbeat.comMaryland State Retirement & Pension System Takes Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)August 17, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Gap Down - Time to Sell?August 16, 2025 | marketbeat.comWhat is Chardan Capital's Estimate for ARWR FY2025 Earnings?August 16, 2025 | marketbeat.comInsider Selling: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Insider Sells 9,389 Shares of StockAugust 16, 2025 | insidertrades.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Shares Up 9.3% - Should You Buy?August 15, 2025 | marketbeat.comWhat is B. Riley's Estimate for ARWR FY2025 Earnings?August 15, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Mutual of America Capital Management LLCAugust 15, 2025 | marketbeat.comArrowhead Pharmaceuticals Advances Plozasiran Study for HypertriglyceridemiaAugust 14, 2025 | tipranks.comArrowhead Pharmaceuticals Shares Drop After Sarepta Sells StakeAugust 14, 2025 | msn.comArrowhead redeems $50M of common stockAugust 14, 2025 | msn.comArrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta TherapeuticsAugust 13, 2025 | businesswire.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Rating Upgraded by B. RileyAugust 13, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Given Buy Rating at Chardan CapitalAugust 12, 2025 | marketbeat.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Releases Quarterly Earnings Results, Misses Expectations By $0.32 EPSAugust 11, 2025 | marketbeat.comOntario Teachers Pension Plan Board Buys Shares of 45,769 Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)August 11, 2025 | marketbeat.comRoyal Bank Of Canada Has Lowered Expectations for Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock PriceAugust 10, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (ARWR) Q3 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comARWR: Countdown to Nov. 18, 2025 PDUFA for Plozasiran for FCS…August 8, 2025 | finance.yahoo.comWhat is Leerink Partnrs' Forecast for ARWR FY2026 Earnings?August 8, 2025 | marketbeat.comArrowhead Pharmaceuticals Reports Fiscal 2025 Third Quarter ResultsAugust 8, 2025 | finance.yahoo.comArrowhead (ARWR) Q3 Revenue Drops 41%August 7, 2025 | fool.comFY2025 Earnings Forecast for ARWR Issued By Leerink PartnrsAugust 7, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Purchased by Privium Fund Management B.V.August 3, 2025 | marketbeat.comVictory Capital Management Inc. Boosts Stock Holdings in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)August 3, 2025 | marketbeat.comGSA Capital Partners LLP Buys 60,018 Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)August 2, 2025 | marketbeat.comArrowhead unit sells rights for plozasiran to Sanofi in Greater ChinaAugust 1, 2025 | msn.comArrowhead Pharmaceuticals (ARWR) to Release Quarterly Earnings on ThursdayAugust 1, 2025 | marketbeat.comArrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough DealJuly 31, 2025 | finance.yahoo.comArrowhead Pharmaceuticals (NASDAQ:ARWR) Upgraded by TD Cowen to Strong-Buy RatingJuly 29, 2025 | marketbeat.comArrowhead, Sarepta Advance on PactJuly 28, 2025 | baystreet.caPinnacle Associates Ltd. Takes Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)July 27, 2025 | marketbeat.comArrowhead Pharmaceuticals Issues Statement on the Status of its Ongoing Agreement with Sarepta TherapeuticsJuly 25, 2025 | finance.yahoo.com Get Arrowhead Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ARWR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARWR Media Mentions By Week ARWR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARWR News Sentiment▼1.291.05▲Average Medical News Sentiment ARWR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARWR Articles This Week▼117▲ARWR Articles Average Week Get the Latest News and Ratings for ARWR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Arrowhead Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Qiagen News Moderna News Verona Pharma PLC American Depositary Share News BridgeBio Pharma News Elanco Animal Health News Roivant Sciences News Grifols News Revolution Medicines News Rhythm Pharmaceuticals News Legend Biotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARWR) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARWR Stock Alerts